AKI Evaluation: Mechanism Before a Label

Clinical Mastery · Visual teaching summary · October 3, 2026

Andrew Bland, MD, FACP, FAAP

Visual summary

Document kidney recovery, persistent dysfunction, and discharge follow-up. AKI increases subsequent kidney risk even when creatinine appears to return toward baseline.

AKI Evaluation: Mechanism Before a Label: six-panel learning summary. Full text follows below.
Download infographic (PNG) · Download Markdown · Read text version ·

Text version

An evolving syndrome

Creatinine and urine output describe complementary features of kidney dysfunction. Compare with a credible baseline and consider the timing of injury, resuscitation, and sampling.

Stabilize threats

Hyperkalemia, pulmonary edema, severe acidemia, uremic complications, and obstruction can require urgent action before the full diagnosis is available.

Localize systematically

Review perfusion, congestion, medications, infection, recent procedures, urinalysis, protein excretion, and urinary tract imaging when indicated.

Reassess interventions

Treat reversible causes, adjust drug dosing, and balance fluid needs against congestion. Repeated assessment is more useful than a one-time prerenal/intrinsic label.

Distinguish draft from published criteria

The KDIGO 2026 AKI/AKD update remains a public-review draft. Proposed biomarker-enhanced staging must be distinguished from published AKI criteria; reassess recommendations when final guidance becomes available.

Follow recovery

Document kidney recovery, persistent dysfunction, and discharge follow-up. AKI increases subsequent kidney risk even when creatinine appears to return toward baseline.

Continue learning

This graphic summarizes a topic. The full educational pages provide the broader discussion and references.